Reciprocal association of plasma IGF-1 and interleukin-6 levels with Cardiometabolic risk factors in nondiabetic subjects

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1886-1888

  Succurro, Elena ^a   Andreozzi, Francesco ^a   Sciaqua, Angela ^a   Hribal, Marta Letizia ^a   Perticone, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SOMATOMEDIN C; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; BLOOD; BODY MASS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEART DISEASE; METABOLISM; MIDDLE AGED;

ADULT; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEART DISEASES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS;

EID: 56149096729     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0553     Document Type: Article

References (9)

1. Festa A, D'Agostino R, Howard G, Myk- kanen L, Tracey RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 101:42-47, 2000
2. Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ: The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 27:2682-2688, 2004
3. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F: Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 28:120-125, 2005
4. Sukhanov S, Higashi Y, Shai SY, Vaughn C, MohlerJ, LiY, Song YH, TitteringtonJ, Delafontaine P: IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterio- scler Thromb Vasc Biol 27:2684-2690, 2007
5. DeBenedetti F, Alonzi T, Moretta A, Laz- zaroD, Costa P, Poli V, Martini A, Cilib- erto G, Fattori E: Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor I. A model for stunted growth in children with chronic inflammation. J ClinInvest 99:643-650,1997
6. Andreozzi F, Laratta E, Cardellini M, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G: Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of italian-caucasian nondiabetic subjects. Diabetes 55:2021-2024, 2006
7. Rajpathak SN, McGinn P, Strickler HD, Rohan TE, Pollak M, Cappola AR, Kuller L, Xue XN, Newman AB, Strotmeyer ES, Psaty BM, Kaplan RC: Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Horm IGF Res 18:166-173, 2007
8. Glund S, Deshmukh A, Long YC, Moller T, Koistinen HA, Caidahl K, Zierath JR, Krook A: Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 56:1630-1637, 2007
9. SuhY, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P: Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 105:3438-3442, 2008